Stock LUPIN LUPIN LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

News Lupin Limited NSE India S.E.

Equities

LUPIN

INE326A01037

Delayed NSE India S.E.
Other stock markets
 03:39:42 2024-04-25 am EDT 		5-day change 1st Jan Change
1,598 INR +1.17% Intraday chart for Lupin Limited +0.28% +20.83%
Apr. 24 Lupin Receives US FDA Inspection Report for Aurangabad, India Manufacturing Facility MT
Apr. 22 INDIA STOCKS-Indian shares rise tracking Asia rebound; drop in HDFC Bank caps gains RE

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Lupin Receives US FDA Inspection Report for Aurangabad, India Manufacturing Facility
MT
Lupin : April 23, 2024 Lupin Receives EIR from U.S. FDA for its Aurangabad Manufacturing Facility
PU
Lupin : April 22, 2024 Lupin Launches Mirabegron Extended-Release Tablets in the United States
PU
INDIA STOCKS-Indian shares rise tracking Asia rebound; drop in HDFC Bank caps gains
RE
Lupin Launches Mirabegron Extended-Release Tablets in US
MT
Lupin : April 12, 2024 U.S. FDA Completes Inspection of Lupin’s Dabhasa Facility with No Observations
PU
US FDA Clears Lupin's API Plant in Gujarat, India, Following GMP Inspection
MT
Lupin Launches Generic Version of Oracea (Doxycycline Capsules) in US
MT
Lupin : April 9, 2024 Lupin Launches First Generic Version of Oracea® (Doxycycline Capsules) in the United States
PU
Lupin Launches Generic Drug for Inflammatory Lesions of Rosacea in US
MT
Lupin Limited Announces the Launch of First Generic Version of Oracea® (Doxycycline Capsules, 40 Mg), in the United States
CI
Lupin : April 8, 2024 Lupin Receives Approval from U.S. FDA for Valbenazine Capsules
PU
Lupin : April 3, 2024 Lupin Appoints Dr. Ranjana Pathak as Chief Quality Officer
PU
Indian Equities Close with Marginal Loss on Wednesday as Traders Scale Down Hopes on US Rate Cuts
MT
Lupin Names Chief Quality Officer
MT
Lupin Limited Announces Change in Management
CI
Lupin : April 1, 2024 Lupin Receives Tentative Approval from U.S. FDA for Migalastat Capsules
PU
Lupin : March 28, 2024 Lupin Receives Approval from U.S. FDA for Eslicarbazepine Acetate Tablets
PU
Lupin to Transfer Trade Generics Business to Subsidiary Lupin Life Sciences
MT
Lupin Limited Receives an Order from the Additional Commissioner of State Tax, Central Division, Patna
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. LUPIN Stock
  4. LUPIN Stock
  5. News Lupin Limited